Signal Management: Updated Requirements of the EAEU Good Pharmacovigilance Practice

The Rules of Good Pharmacovigilance Practice of the Eurasian Economic Union (EAEU GVP Guideline) came into force in the EAEU Member States in 2017. Over the next 5 years, marketing authorisation holders and competent authorities managed to build effective pharmacovigilance systems. The current versi...

Full description

Saved in:
Bibliographic Details
Main Authors: A. V. Matveev, A. E. Krasheninnikov, A. Yu. Zelinskaya
Format: Article
Language:Russian
Published: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2023-03-01
Series:Безопасность и риск фармакотерапии
Subjects:
Online Access:https://www.risksafety.ru/jour/article/view/355
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849252368866082816
author A. V. Matveev
A. E. Krasheninnikov
A. Yu. Zelinskaya
author_facet A. V. Matveev
A. E. Krasheninnikov
A. Yu. Zelinskaya
author_sort A. V. Matveev
collection DOAJ
description The Rules of Good Pharmacovigilance Practice of the Eurasian Economic Union (EAEU GVP Guideline) came into force in the EAEU Member States in 2017. Over the next 5 years, marketing authorisation holders and competent authorities managed to build effective pharmacovigilance systems. The current version of the EAEU GVP Guideline was published in May 2022 and enacted on 6 December 2022. Amongst the critical pharmacovigilance processes, a special place is reserved to the process of signal management.The aim of the study was to analyse the new content of the EAEU GVP Guideline related to signal management.The authors reviewed the amendments introduced to the module of the EAEU GVP Guideline on signal management. This article is the first scholarly publication in the Russian language on the updated signal management process. The key changes include a detailed consideration of terminology issues, signal validation and prioritisation processes, notifying competent authorities of signal evaluation results, managing emerging safety issues, and functions of new automated systems: an integrated database of adverse drug reactions and a system for tracking safety issues.
format Article
id doaj-art-3e6f5f3e75e54970ae323c9159f0d78e
institution Kabale University
issn 2312-7821
2619-1164
language Russian
publishDate 2023-03-01
publisher Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
record_format Article
series Безопасность и риск фармакотерапии
spelling doaj-art-3e6f5f3e75e54970ae323c9159f0d78e2025-08-20T03:56:38ZrusMinistry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»Безопасность и риск фармакотерапии2312-78212619-11642023-03-01111384510.30895/2312-7821-2023-11-1-38-45287Signal Management: Updated Requirements of the EAEU Good Pharmacovigilance PracticeA. V. Matveev0A. E. Krasheninnikov1A. Yu. Zelinskaya2National Pharmacovigilance Research Center; Russian Medical Academy of Continuous Professional EducationNational Pharmacovigilance Research Center; N.I. Pirogov Russian National Research Medical UniversityNational Pharmacovigilance Research CenterThe Rules of Good Pharmacovigilance Practice of the Eurasian Economic Union (EAEU GVP Guideline) came into force in the EAEU Member States in 2017. Over the next 5 years, marketing authorisation holders and competent authorities managed to build effective pharmacovigilance systems. The current version of the EAEU GVP Guideline was published in May 2022 and enacted on 6 December 2022. Amongst the critical pharmacovigilance processes, a special place is reserved to the process of signal management.The aim of the study was to analyse the new content of the EAEU GVP Guideline related to signal management.The authors reviewed the amendments introduced to the module of the EAEU GVP Guideline on signal management. This article is the first scholarly publication in the Russian language on the updated signal management process. The key changes include a detailed consideration of terminology issues, signal validation and prioritisation processes, notifying competent authorities of signal evaluation results, managing emerging safety issues, and functions of new automated systems: an integrated database of adverse drug reactions and a system for tracking safety issues.https://www.risksafety.ru/jour/article/view/355safety signalemerging safety issuespharmacovigilancegood pharmacovigilance practicedrug safety
spellingShingle A. V. Matveev
A. E. Krasheninnikov
A. Yu. Zelinskaya
Signal Management: Updated Requirements of the EAEU Good Pharmacovigilance Practice
Безопасность и риск фармакотерапии
safety signal
emerging safety issues
pharmacovigilance
good pharmacovigilance practice
drug safety
title Signal Management: Updated Requirements of the EAEU Good Pharmacovigilance Practice
title_full Signal Management: Updated Requirements of the EAEU Good Pharmacovigilance Practice
title_fullStr Signal Management: Updated Requirements of the EAEU Good Pharmacovigilance Practice
title_full_unstemmed Signal Management: Updated Requirements of the EAEU Good Pharmacovigilance Practice
title_short Signal Management: Updated Requirements of the EAEU Good Pharmacovigilance Practice
title_sort signal management updated requirements of the eaeu good pharmacovigilance practice
topic safety signal
emerging safety issues
pharmacovigilance
good pharmacovigilance practice
drug safety
url https://www.risksafety.ru/jour/article/view/355
work_keys_str_mv AT avmatveev signalmanagementupdatedrequirementsoftheeaeugoodpharmacovigilancepractice
AT aekrasheninnikov signalmanagementupdatedrequirementsoftheeaeugoodpharmacovigilancepractice
AT ayuzelinskaya signalmanagementupdatedrequirementsoftheeaeugoodpharmacovigilancepractice